Early research (Phase 1)Active Not RecruitingNCT07063849What this trial is testingPilot Influenza Challenge StudyWho this might be right forInfluenza Daniel Hoft, MD, PhD 12
Early research (Phase 1)Study completedNCT02877160What this trial is testingAssess the PK of AL-794 Formulations in Healthy SubjectsWho this might be right forInfluenza Alios Biopharma Inc. 31
Not applicableStudy completedNCT05078060What this trial is testingSafety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2021/22Who this might be right forInfluenza (Healthy Volunteers) Sanofi Pasteur, a Sanofi Company 1,804
Testing effectiveness (Phase 2)Study completedNCT05284799What this trial is testingImmunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers.Who this might be right forInfluenza Osivax 180
Testing effectiveness (Phase 2)Study completedNCT05519839What this trial is testingEvaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination VaccineWho this might be right forCOVID-19Influenza Novavax 1,579
Early research (Phase 1)WithdrawnNCT00540501What this trial is testingEvaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy SubjectsWho this might be right forHealthy Subjects GlaxoSmithKline
Early research (Phase 1)UnknownNCT01929382What this trial is testingDetermining the Effect of Actimmune (Interferon Gamma 1b)Dose Titration on Flu-Like Symptoms in Healthy VolunteersWho this might be right forAdverse Effects in the Therapeutic Use of Interferon Vidara Therapeutics Research Ltd 40
Post-approval studies (Phase 4)Study completedNCT01113580What this trial is testingA Clinical Trial of CSL's 2010/2011 Formulation of Enzira® in a Healthy Adult PopulationWho this might be right forInfluenza Seqirus 120
Post-approval studies (Phase 4)Study completedNCT00888381What this trial is testingAssess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy VolunteersWho this might be right forInfluenza Seqirus 120
Early research (Phase 1)Study completedNCT01990846What this trial is testingSafety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy SubjectsWho this might be right forInfluenza Autoimmune Technologies, LLC 68
Early research (Phase 1)Study completedNCT01443936What this trial is testingExperimental AD4-H5-VTN Vaccine in Healthy VolunteersWho this might be right forH5N1 Influenza National Institute of Allergy and Infectious Diseases (NIAID) 96
Testing effectiveness (Phase 2)Study completedNCT06361875What this trial is testingInvestigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and AboveWho this might be right forInfluenza ImmunizationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 908
Very early researchStudy completedNCT04484532What this trial is testingEvaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy VolunteersWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome Roswell Park Cancer Institute 130
Testing effectiveness (Phase 2)Study completedNCT01841918What this trial is testingSafety and Immunogenicity of Live Attenuated Influenza H5N2Who this might be right forInfluenza Due to Influenza A Virus Subtype H5N2 Mahidol University 150
Not applicableNot Yet RecruitingNCT07282795What this trial is testingPost-marketing Surveillance Study for the Safety of Efluelda® Pre-filled SyringeWho this might be right forInfluenza ImmunizationHealthy Volunteers Sanofi 670
Early research (Phase 1)Study completedNCT05955027What this trial is testingEvaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy SubjectsWho this might be right forInfluenza, Human Nanjing Zenshine Pharmaceuticals 24
Post-approval studies (Phase 4)Study completedNCT01356342What this trial is testingImmunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years OldWho this might be right forInfluenza Adimmune Corporation 181
Not applicableLooking for participantsNCT06620185What this trial is testingGEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuEWho this might be right forInfluenza Imperial College London 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT05569239What this trial is testingEfficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μgWho this might be right forInfluenza Osivax 2,850
Early research (Phase 1)Study completedNCT01657929What this trial is testingH5-VLP + GLA-AF Vaccine Trial in Healthy Adult VolunteersWho this might be right forInfluenza A Subtype H5N1 Infection Access to Advanced Health Institute (AAHI) 105